
Arrowhead Pharmaceuticals (ARWR) Earnings Dates & Reports
Arrowhead Pharmaceuticals (ARWR) Most Recent Earnings
Report DateAug 7, 2025
Period EndingQ3 2025
Est. EPS-$1.04
Actual EPS-$1.26
EarningsMiss
Arrowhead Pharmaceuticals (ARWR) Earnings
View the latest Arrowhead Pharmaceuticals (ARWR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Arrowhead Pharmaceuticals (ARWR)
Order type
Buy in
Order amount
Est. shares
0 shares
Arrowhead Pharmaceuticals (ARWR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Arrowhead Pharmaceuticals (ARWR) Latest Earnings
The value each ARWR share was expected to gain vs. the value each share gained.
Arrowhead Pharmaceuticals (ARWR) reported its most recent earnings on Aug 7, 2025 for Q3 2025, posting earnings per share (EPS) of -$1.26. This exceeded analysts' expectations of -$1.04 by 21.15%, marking a Miss.
For comparison, Arrowhead Pharmaceuticals reported EPS of -$1.38 in the same quarter last year.
The company is expected to announce its next earnings report on 11/25/2025, with analysts projecting an EPS of -$0.18.
Arrowhead Pharmaceuticals (ARWR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q4 2025Nov 25, 2025 | -$0.18 | Next earnings call Nov. 25, 2025 | ||
Q3 2025Aug 7, 2025 | -$1.04 | -$1.26 | +21.15% | |
Q2 2025May 12, 2025 | -$0.46 | $2.75 | -697.83% | |
Q1 2025Feb 10, 2025 | -$0.72 | -$1.39 | +93.06% | |
Q4 2024Nov 26, 2024 | -$0.92 | -$1.37 | +48.91% | |
Arrowhead Pharmaceuticals (ARWR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Arrowhead Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 7, 2025 | — | — | — |
May 12, 2025 | — | — | — |
Feb 10, 2025 | — | — | — |
Nov 26, 2024 | — | — | — |
Arrowhead Pharmaceuticals (ARWR) Earnings FAQs
Arrowhead Pharmaceuticals (ARWR) last reported earnings on Aug 7, 2025 for Q3 2025, posting an EPS of -$1.26, which Miss the estimate of -$1.04 by 21.15%.
For Q3 2025, Arrowhead Pharmaceuticals (ARWR) reported an EPS of -$1.26, missing analysts' estimate of -$1.04 by 21.15%.
For Q3 2025, Arrowhead Pharmaceuticals (ARWR) Miss expectations with an actual EPS of -$1.26 vs. an estimated EPS of -$1.04.
Following the last earnings report on Aug 7, 2025, Arrowhead Pharmaceuticals (ARWR)'s stock price moved — from — to —.
The next Arrowhead Pharmaceuticals (ARWR) earnings call is scheduled for Nov. 25, 2025, where executives will discuss financial results and outlook.